Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Do OTC shells still get acquired? Seems this and other related boards have gone very quiet.
$AVOI Early here--8K Change of control filed 4-24... I think we see something very nice come into AVOI... New owner has million$ and many business contacts... I don't think they spent this kind of money to let it sit for long...
Bet we find out what is coming in soon...
Big 30k bid at .3 Lift-off >>>>$$$ get in or miss the run to $6.00
Awesome I’ll be on the bid in the morning
$CLHI
Still in looking as if $CLHI may go soon
And even better! $BWVI the future just keeps on getting better and better wow
https://psychedelicalpha.com/news/breaking-morgan-stanley-publishes-optimistic-report-on-psychedelics
$BWVI Just keeps getting better
We're honored to be named among some of the top psychedelic companies on @USNewsMoney's List of 7 Psychedelic Stocks to Watch. #mentalhealth #biotechnewshttps://t.co/40Rzfo0A0Y
— Psycheceutical (@psycheceutical) August 1, 2022
$BWVI had a major L2 shift last week and making its moves back up. Ticker Change from FINRA any day and post that, news roll out and investors coming in, expecting significant uptick over next few weeks. Low locked float, very primed and great scenario
Well worth solid DD
$BWVI
Do you guys live in Canada? Are you able to buy it right now on the expert market? If not, why should anyone care about this stock? I remember the gold 'ol days when people who did their DD could capitalize on filings and get in on the bottom floor of plays like this and make money. The new SEC rules have killed it now. So again, who should care? This market is dead.
ThanX... Nice move underway
$ZONX That was an old case. This one was closed. New here: granted
new : A-22-850895-P Result Granted
https://www.clarkcountycourts.us/Portal/Case/CaseDetail?eid=C1RdKQKV4SUqdKhv3EBDIQ2&tabIndex=3
old : A-21-834698-P
https://www.clarkcountycourts.us/Portal/Case/CaseDetail?eid=l5bJa3BlYXNlvx8CyBHNMA2&tabIndex=3
iPhone, iMac, ilst, and ilim. I’m ready.
$BWVI HUGE Psycheceutical Brings on Kevin Harrington, the original shark from Shark Tank as Investor and Strategic Advisor
Psycheceutical Brings on Original Shark from 'Shark Tank,' Kevin Harrington, as Investor and Strategic Advisor
May 10, 2022 (PRNewswire via COMTEX) -- PR Newswire
MIAMI, May 10, 2022
Famed entrepreneur excited about the company's development of psychedelic pharmaceutical medicines to treat the widespread mental health crisis
MIAMI, May 10, 2022 /PRNewswire/ -- Psycheceutical, Inc. (a wholly owned subsidiary of Psycheceutical Bioscience, Inc. (OTC: BWVI), a biopharmaceutical company dedicated to the development and commercialization of psychedelic medicines, today announced the addition of original Shark Tank entrepreneur Kevin Harrington as the corporation's newest investor and strategic advisor. Harrington joins Psycheceutical to provide expertise on the strategy, direction, and execution of the company's growth and development in pursuit of its mission to accelerate the research, availability, and delivery of safer and more effective psychedelic pharmaceutical medicines.
"The world is undergoing an unprecedented mental health crisis. We all know someone who is suffering from depression, anxiety, or addiction. What we've been doing isn't working," said Harrington. "We need a different approach to treatment, and psychedelic medicines have shown incredible promise where conventional medicines have failed. It seems clear to me that psychedelics are the future of mental health treatment, but they need to be delivered safely like pharmaceutical medicines, which is why I'm so excited about Psycheceutical."
"I've been watching the emerging psychedelic medicine industry and looking for investment opportunities. I chose to invest in and join Psycheceutical because of their patented next-generation delivery technologies, designed to increase the safety and efficacy of psychedelic compounds without the hallucinogenic side effects. As an entrepreneur who is trying to help people and make a positive impact with my investments, these kinds of opportunities don't come up that often: real solutions to help alleviate real suffering for millions of people," added Harrington.
As an original shark on the hit TV show Shark Tank, the creator of the infomercial, and pioneer of the As Seen on TV brand, Kevin Harrington's business ventures have launched more than 1,000 products and produced well over $6 billion in global sales. More than 20 of Harrington's companies have each topped $100 million in revenue.
"We are thrilled to have Kevin Harrington on board as an investor and advisor, and we greatly appreciate his passion for mental health and for bringing awareness to cutting-edge psychedelic treatments as a way to solve this mental health epidemic," said Chad Harman, CEO of Psycheceutical. "Kevin has worked with some of the world's biggest celebrities and launched some of the best-selling campaigns in history. His expertise is invaluable as we execute our mission to facilitate the widespread availability of safer and more effective psychedelic pharmaceutical medicines."
https://www.marketwatch.com/press-release/psycheceutical-brings-on-original-shark-from-shark-tank-kevin-harrington-as-investor-and-strategic-advisor-2022-05-10?mod=mw_quote_news_seemore
$BWVI News, remember this hasn't even started. This is heading to the ticker change and then the show begins. Leading up to it though, very exciting!
Psycheceutical Announces Julian Bailes, M.D. as Principal Medical Advisor
MIAMI, March 1, 2022 /PRNewswire via COMTEX/ -- MIAMI, March 1, 2022 /PRNewswire/ -- Psycheceutical, Inc. (a wholly-owned subsidiary of Blue Water Ventures International, Inc. (OTC: BWVI), a bioscience company dedicated to the development and commercialization of psychedelic medicines, today announced the addition of Dr. Julian Bailes as Principal Medical Advisor. Bailes will participate in the strategy, direction, and execution of the company's clinical and technology development in pursuit of its mission to accelerate the research, availability, and delivery of safe and effective psychedelic pharmaceutical medicines.
Bailes is a recognized leader in the field of neurosurgery and the impact of brain injury on brain function. His expertise in the field of chronic traumatic encephalopathy (CTE) is showcased in the 2015 film "Concussion," starring Will Smith, where Bailes is portrayed by actor Alec Baldwin. CTE is a progressive degenerative disease found in individuals who have sustained repetitive head impacts, multiple concussions or other forms of head injury. His expertise includes cranial surgery, traumatic brain injury, PTSD, and CTE.
Bailes is the chairman of the Department of Neurosurgery at the NorthShore University Health System and co-director of the NorthShore Neurological Institute, both located in Evanston, Ill. He also serves as Chairman of the Pop Warner Football Medical Advisory Committee. As Principal Medical Advisor for Psycheceutical, Bailes will be a key advisor to both the senior management team and the board of directors, which determine and oversee the company's drug development activities.
"Dr. Bailes brings critical knowledge of the central nervous system and a shared mission of making vital psychedelic therapies available to the people who need them as quickly and safely as possible," said Chad Harman, CEO, Psycheceutical. "His depth of knowledge and proven leadership track record will be essential to bringing our patented psychedelic delivery technologies to market and, ultimately, strengthening the broader psychedelic pharmaceutical industry as a whole."
With more than 300 scientific publications concerning various aspects of neurosurgery and editorial assignments for a number of medical journals, Dr. Bailes' reputation in the field of neurosurgery will bring further academic expertise to the emerging field of psychedelic medicine.
"The psychedelic pharmaceutical industry is primed for technological improvements in how these powerful medicines are developed and delivered to patients," commented Dr. Bailes. "I am excited to be working with a company at the forefront of helping bring these products to market in a safe, efficient way."
About Psycheceutical, Inc.
Psycheceutical, Inc. is the wholly-owned subsidiary of Blue Water Ventures International, Inc. (OTC: BWVI). Psycheceutical is developing cutting-edge delivery technologies to support safe and effective psychedelic pharmaceutical medicines. Powered by a team with more than 100 years' combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry, Psycheceutical is on a mission to bring safety and efficacy to psychedelic compounds. Learn more at Psycheceutical.com.
Forward-Looking Statements:
Certain statements in this news release related to the Company constitute "forward-looking information" within the meaning of applicable securities laws and are prospective in nature. Forward-looking information is not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These uncertainties include, but are not limited to, (i) general market growth for and acceptance of psychedelic-inspired medicines, (ii) capital and credit availability and market volatility, (iii) general economic conditions, (iv) governmental approvals and compliance with regulations, (v) product research and development and clinical trial risks, (vi) incorrect underlying assumptions, and (vii) our future business development, results of operations, and financial condition. These statements generally can be identified using forward-looking words such as "will," "may," "should," "could," "intend," "estimate," "plan," "anticipate," "expect," "believe," "potential" or "continue," or the negative thereof or similar variations. All information provided in this press release is as of the date of this press release, and we undertake no duty to update such information, except as required under applicable law.
Contact:
Dianne Gleason
highmountaincomms@gmail.com
https://www.marketwatch.com/press-release/psycheceutical-announces-julian-bailes-md-as-principal-medical-advisor-2022-03-01?mod=mw_quote_news_seemore
i'm in for the next merger try. $CLHI
$BWVI Psycheceutical players. I've posted before on the RM for
$BWVI w/ psycheceutical.com/
Merger completed last month ands progressing well. First SEC filing is in, along with the updated name in the NVSOS. (You won't find the old company name anywhere.) I encourage you to review the investor deck, see what the company is all about. If not interested, at least you know about other players in the space and what they up to. It is good DD as part of any psycheceutical companies you invest in.
Psycheceutical doing the corporate change over right now, ticker will get changed after final regulatory fillings (rubber stamp back end of the RM process) but then investor roadshow and all news start coming out. They have been a private company in stealth mode and going to unleash! This is just getting started.
Great product and team, serious incoming player imo and we are still very undervalued (Again READ the investor deck) and undiscovered at this point. But imo the future looks significantly optimistic.
Lots of you tube videos on Zappy as well, just search.
Its good DD either way, knowledge is power.....
psycheceutical.com/investors/
$BWVI Its DONE! Definitive done! Like I have been saying for a few months! The future looks incredibly bright!
Tweet: @Psycheceutical Inc., today announced the company has been fully acquired by Blue Water Ventures International, Inc. (OTCPK: $BWVI)." Read more from today's announcement:
Psycheceutical Completes Acquisition by Blue Water Ventures International
Press Release | 01/20/2022
Miami, FL, Jan. 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Psycheceutical, Inc., a biotechnology company dedicated to the development and commercialization of psychedelic medicines, today announced the company has been fully acquired by Blue Water Ventures International, Inc. (OTCPK: BWVI).
“We are thrilled that this deal has closed and that Psycheceutical is now a wholly-owned subsidiary of a publicly-listed company and has secured important near-term capital to pursue our growth plans,” commented Psycheceutical CEO Chad Harman. “We will immediately begin the next steps of our growth strategy as we work to bring our revolutionary psychedelic drug delivery technologies to the market, starting with initial clinical trials.”
BWVI acquired Psycheceutical, Inc. by way of a merger, resulting in Psycheceutical becoming a wholly-owned subsidiary of BWVI. Now that the acquisition has occurred, BWVI intends to cease its previous business activities and the company will focus solely on psychedelic drug development. Once regulatory approvals have been received, the company will consummate related corporate actions, including a name and symbol change.
About Psycheceutical, Inc.
Psycheceutical, Inc. is seeking to develop cutting-edge delivery technologies for safe and effective psychedelic pharmaceutical medicines. Powered by a team with more than 100 years' combined experience in development, regulatory approval processes and commercialization across the pharmaceutical industry, Psycheceutical is on a mission to bring safety and efficacy to psychedelic compounds. Learn more at Psycheceutical.com.
Jeffrey Bahnsen
407-808-5700
jeff@bahnsenlaw.com
"@Psycheceutical, Inc., today announced the company has been fully acquired by Blue Water Ventures International, Inc. (OTCPK: $BWVI)."
— Psycheceutical (@psycheceutical) January 20, 2022
Read more from today's announcement: https://t.co/mAnSg6wHQr pic.twitter.com/QKORds18u9
$BWVI Up 350% since started covering here, and LOTS of room to run.... Just saying! You REALLY should be doing DD here!
RM definitive with Psycheceutical.com to drop any day! This week looks very promising! The DD continues to line up for the RM Definitive! DD supports x10 ROI
Be sure to do your own DD and verify everything!
The OS was just updated. The commons changed only a tiny bit, like 350k, but the restricted shares went up 35M, this is in essence imo the control block for psycheceutical management.
Just that last bit, the definitive dropping! And the conference would be an awesome place to mention the new pubco!
Lastest News:
Zappy, Chief Visionary Officer, and Kaia Roman, V.P. of Strategy & Communications, will be presenting at Cannadelic Miami, the world’s first cannabis & psychedelics expo, on Feb 5-6, 2022:
flmjexpo.com/
Everything that has come before this:
10-7 NV Biz Reg updated: https://esos.nv.gov/EntitySearch/OnlineEntitySearch
11-3 LOI IN:
https://www.otcmarkets.com/stock/BWVI/news/Blue-Water-Ventures-International-Inc-Signs-Non-Binding-Letter-of-Intent-to-Acquire-Psycheceutical-Inc?id=328933
11-4 COC IN:
https://www.otcmarkets.com/otcapi/company/financial-report/309560/content
The CoC brought in management whose history is facilitating RM's. They are not here to run the old company, the are here for the shell to a new pubco with great potential, great tech, great industry.
SS: 106,634,589 Restricted 82,071,048 (Up ~35M on 1/13/22 Unrestricted 24,563,541 (only like 350k up!) float: 24,163,541
https://www.otcmarkets.com/stock/BWVI/security
Now just waiting for definitive to hit, and it is looking very good for the near future!
Checking a comparison of other companies in the industry to see what kind of evaluation we should get post merger. Plenty will depend on what kind of news they put out, but if we look at the average of all market caps and what BWVI will be post RM, its already x10. Check the reference chart below.
$BWVI even higher now, Looks optimistic to drop next week! Boomage x5-20 coming IMO from all the DD available and verifiable.
Based on SS just Updated 1/13, restricted gone up. This would only be for the RM, oh man, looking so good! Do your DD!!!
0.5950
Pink Current, AS: 300M, OS: 106M, US: 24M
Outstanding Shares Updated:
70,844,180 (2021-10-11)
106,634,589 (2022-01-13)
Difference: +50.5% (+35M)
Restricted Shares Updated:
46,630,639 (2021-10-11)
82,071,048 (2022-01-13)
Difference: +76.0% (+35M)
Unrestricted Shares Updated:
24,213,541 (2021-10-11)
24,563,541 (2022-01-13)
Difference: +1.4% (+350K)
Chart, OTC Profile, Twitter, @otcupdates
Update: 2022-01-13 23:17:28 (UTC)
consolidating some $lithium & graphene $igex
$IGEX for the win $$
YES I LIKE $IGEX LOTS THE MINERAL COMPANY
time tells all
YES ON $ACCR LAST IS GOING E.V. ????? METAVERSE ????? DIGITAL CURRENCY ?????
hi mick. i haven't heard anything
ANY UPDATE FER $ACCR ?????
$BWVI .6250 now, just saying if been following my posts here....
Do your DD!
$BWVI .56, just saying more green and looks great, go do the DD!
$VHUB Robert Kropf shell, atty letter coming, Yield now, Pink coming. Kropf knows what he's doing with finding R/M candidates.
Float only 261K shares
$BWVI $.50 now, well not a lot of posts on this board, but still lots of room to go and definitive coming still, just heating up!
Can't say I didn't mention it, my post story right here lol
$BWVI Well now we almost double and its thiiiiiin up top. When you have a crazy low 70M OS and low low 25M float just not much selling and it just keeps rising!
$BWVI up 40% since the announcement. It continues to do well while waiting for that final 8K to come in!
Just a matter of time. These guys have a history of success with it, thats all they do!
$BWVI
Going to be great:
Www.Psycheceutical.com
$BWVI Boom! CoC Filing Already out!!!
https://www.otcmarkets.com/otcapi/company/financial-report/309560/content
This Train is running fast!!!
Looking forward to the RM!!!
The goal of this disclosure is to provide information with respect to a company’s Change of Control event. Please address each of the below items to the best of the company’s ability and to the extent
they are applicable to the company’s Change of Control event.
Disclosure of Change in Control and Other Material Events:
1. A description of event(s) and relevant date(s) resulting in the Change in Control. Effective September 30, 2021, the two members of the board of directors of Blue Water Ventures International, Inc. (the "Company"), Larry Hoogendoorn and W. Keith Webb, resigned and Bruce Cassidy and Roger Tichenor were appointed to the Company's board of directors to fill the two vacancies. Mr. Webb also tendered his resignation as the Company's Principal Executive Officer and Chief Executive Officer; and Elizabeth Webb tendered her resignation as the Company's Secretary and Treasurer. Both resignations were effective September 30, 2021. The Company filled the officer vacancies by appointing Roger Tichenor the Company's Principal Executive Officer, Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer, also effective September 30, 2021.
2. The name(s) of person(s) who acquired control and person(s) from whom control was assumed. For corporations or other business entities, please provide the name(s) of person(s) beneficially owning or controlling such corporations or entities.2 Also, effective September 30, 2021, W. Keith Webb sold 8,813,515 shares of common stock and 300 shares of Series A preferred stock (each 100 shares of which is convertible into 1% of the outstanding shares of common stock on a fully diluted basis) to each of Roger Tichenor and Jeffery Bahnsen in exchange for an aggregate amount of $100,000.
$BWVI RM With Psycheceutical!!!
This is going to be one of the biggest RM otc plays seen in a long time. Do your DD, checks the names these are big dogs getting a great shell, but they are here for otc this is NQ bound!
https://psycheceutical.com/
Great technology:
https://psycheceutical.com/technology/
Forbes article:
https://www.forbes.com/sites/benjaminadams/2021/09/17/armed-with-two-patents-psycheceutical-plans-to-transform-psychedelic-drug-delivery/?sh=449fdedb2396
https://www.otcmarkets.com/stock/BWVI/news/Blue-Water-Ventures-International-Inc-Signs-Non-Binding-Letter-of-Intent-to-Acquire-Psycheceutical-Inc?id=328933
Blue Water Ventures International, Inc. Signs Non-Binding Letter of Intent to Acquire Psycheceutical, Inc.
Press Release | 11/03/2021
Miami, FL, Nov. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Blue Water Ventures International, (OTC: BWVI), has signed a non-binding letter of intent which contemplates a proposed acquisition of Psycheceutical, Inc. Following the closing of the anticipated acquisition, Psycheceutical would emerge as the surviving company with a name and symbol change to follow.
“The closing of this acquisition marks a pivotal event that will provide Psycheceutical with the opportunity to achieve its next level of corporate growth as we advance our promising psychedelic drug delivery technologies,” said Chad Harman, Psycheceutical CEO.
Completion of the transaction is subject to due diligence investigations by the relevant parties, the negotiation and execution of a definitive share exchange agreement, satisfaction of the conditions negotiated therein including the approval of the Company's Board of Directors, and the satisfaction of other customary closing conditions. There can be no assurance that a definitive agreement will be entered into or that the proposed transaction will be consummated. Further, readers are cautioned that those portions of the LOI that describe the proposed transaction, including the consideration to be issued therein, are non-binding.
About Psycheceutical, Inc.
Psycheceutical, Inc. is using cutting-edge delivery technologies to develop safe and effective psychedelic pharmaceutical medicines. Powered by a team with more than 100 years' combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. Psycheceutical is on a mission to bring safety and efficacy to psychedelic compounds. Learn more at Psycheceutical.com.
Forward-Looking Statements
This press release contains forward-looking statements. Statements in this press release that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, references to business and development plans. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this press release, and Blue Water Ventures International assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents filed with available at www.otcmarkets.com.
Contact:
BWVI Investor Relations
Roger Tichenor, CEO
rogeratichenor@gmail.com
(941) 345-5531
Psycheceutical, Inc. Investor Relations
Michael Hlavsa, CFO
michael.hlavsa@psycheceutical.com
(954) 868-7366
Kaia Roman, VP, Strategy & Communications
kaia.roman@psycheceutical.com
(831) 295-2111
EPIC REVERSE MERGER JUST ANNOUNCED 2 MINUTES AGO! BWVI!!!!!
With Psycheceutical!!!
https://psycheceutical.com/
https://www.otcmarkets.com/stock/BWVI/news/Blue-Water-Ventures-International-Inc-Signs-Non-Binding-Letter-of-Intent-to-Acquire-Psycheceutical-Inc?id=328933
Blue Water Ventures International, Inc. Signs Non-Binding Letter of Intent to Acquire Psycheceutical, Inc.
Press Release | 11/03/2021
Miami, FL, Nov. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Blue Water Ventures International, (OTC: BWVI), has signed a non-binding letter of intent which contemplates a proposed acquisition of Psycheceutical, Inc. Following the closing of the anticipated acquisition, Psycheceutical would emerge as the surviving company with a name and symbol change to follow.
“The closing of this acquisition marks a pivotal event that will provide Psycheceutical with the opportunity to achieve its next level of corporate growth as we advance our promising psychedelic drug delivery technologies,” said Chad Harman, Psycheceutical CEO.
Completion of the transaction is subject to due diligence investigations by the relevant parties, the negotiation and execution of a definitive share exchange agreement, satisfaction of the conditions negotiated therein including the approval of the Company's Board of Directors, and the satisfaction of other customary closing conditions. There can be no assurance that a definitive agreement will be entered into or that the proposed transaction will be consummated. Further, readers are cautioned that those portions of the LOI that describe the proposed transaction, including the consideration to be issued therein, are non-binding.
About Psycheceutical, Inc.
Psycheceutical, Inc. is using cutting-edge delivery technologies to develop safe and effective psychedelic pharmaceutical medicines. Powered by a team with more than 100 years' combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. Psycheceutical is on a mission to bring safety and efficacy to psychedelic compounds. Learn more at Psycheceutical.com.
Forward-Looking Statements
This press release contains forward-looking statements. Statements in this press release that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, references to business and development plans. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this press release, and Blue Water Ventures International assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents filed with available at www.otcmarkets.com.
Contact:
BWVI Investor Relations
Roger Tichenor, CEO
rogeratichenor@gmail.com
(941) 345-5531
Psycheceutical, Inc. Investor Relations
Michael Hlavsa, CFO
michael.hlavsa@psycheceutical.com
(954) 868-7366
Kaia Roman, VP, Strategy & Communications
kaia.roman@psycheceutical.com
(831) 295-2111
BATON ROUGE, LA, Oct. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Rogue Station Companies, Inc. (OTCMkts: RGST) announced today it has executed a business combination LOI with Everdime Technology, Inc., a multi-disciplinary cryptocurrency technology innovator, with a current emphasis on use of tokens and NFTs to monetize social networks for operators and participants. Its principals have developed technologies and a suite of applications that provide infrastructure for the generation of Fan Tokens and NFTs using the ERC20 blockchain, providing a safe, secure, and effective method for users to create, buy, and trade NFTs and cryptocurrencies.
John Conroy, CEO of RGST, expressed his excitement about future growth opportunities. “Everdime checks all the boxes for an ideal combination candidate for RGST. The company is positioned in an exploding industry and has a well-defined Business Plan and experienced management team.”
Sandor Miklos, CEO of Everdime Technologies, Inc stated, “Everdime is on the cutting edge of one of the fastest growing segments within the crypto space and RGST offers the public vehicle necessary to accomplish the expansion opportunities of the company. Our mission is to be a catalyst for faster crypto adoption by removing the barriers to the crypto revolution and empowering our users with an easy-to-use platform which diversifies and grows their portfolio while minimizing risk and maximizing reward on their investments.” Everdime is domiciled in Sheridan, Wyoming and operates out of Ontario, Canada.
Market analysts note that Blockchain adoption is still in its infancy, just as the internet was in its early years. The cryptocurrency industry has grown in the past five years, recently surpassing the $2 trillion market value. With just 130 million Bitcoin users globally, this compares to the internet's adoption rate in 1997, when many believed it would be a fad. Cryptocurrency-enabled currencies, including user-sponsored Fan Tokens and NFTs, are reshaping the future of finance and changing the way value is recognized, stored, transferred, and spent.
ABOUT THE COMPANIES
Rogue Station Companies, Inc. is a Delaware corporation that conducts business from Baton Rouge, Louisiana. It is currently a “shell” company, seeking an acquisition target that has an expandable business model and secured funding. Information about the Company can be obtained at otcmarkets.com. Everdime Technologies, Inc. is a Wyoming corporation that conducts business from Ontario, Canada. Information about the company can be obtained at everdime.com.
SAFE HARBOR STATEMENT
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports posted on ARS with OTC Markets Group, Inc. at www.otcmarkets.com. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.
Contact: John Conroy, CEO
Corporate Services Rogue Station Companies, Inc.
225-273-1100
RGST - Rogue Station Companies, Inc.
Company is current with no business. Current CEO and major owner John Conroy has kept this shell clean and does not allow toxic financing. He is looking for an ideal candidate.
Fillings on the otc are up to date - unchanged share structure for years. Float is below 5 million shares.
RGST SECURITY DETAILS
Share Structure
Market Cap Market Cap
2,133,779
09/20/2021
Authorized Shares
250,000,000
09/16/2021
Outstanding Shares
31,379,098
09/16/2021
Restricted
25,953,098
09/16/2021
Unrestricted
5,426,000
09/16/2021
Held at DTC
Not Available
Float
4,924,584
12/31/2020
Par Value
0.0001
Last updated - 09/21/2021
PSSS on the top of the list!
https://www.barchart.com/stocks/sectors/penny-stocks?orderBy=percentChange5d&orderDir=desc
PSSS & GBEI out of nowhere went from dark to yield. Pink coming...
$MTRT 7mil float R/M South Korean crypto play:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165723842
****MUST READ*****MEDIUM INC. MERGING OWNER MTRT- Hankyung.com : CEO Kim Pan-Jong of Medium Sits Down with the Electronic Times for an Exclusive Interview
NEWS PROVIDED BY
Hankyung.com
Dec 09, 2020, 00:22 ET
SHARE THIS ARTICLE
SEOUL, South Korea, Dec. 7, 2020 /PRNewswire/ -- Blockchain has been seen as a technology that will lead the future for many years. However, only a very small number of blockchain services has actually been commercialized.
http://pr.hankyung.com/wp-content/uploads/2020/12/KakaoTalk_20201208_124726419.jpg
Kim Pan-jong of Medium (Source: Medium)>
Medium, a South Korean company specializing in blockchain, analyzed that lack of performance as the main reason why commercialization of blockchain technologies has been slow and it has been focusing on technology development in order to implement high-performance blockchain technology.
The Electronic Times met with CEO Kim Pan-jong of Medium and listened to his explanation about his company's plan for future blockchain technology.
Q. Please introduce about your company Medium.
A. Medium is a blockchain startup that was established in October of 2018 and it has been focusing on blockchain technology with a confidence that blockchain technology will be a necessary technology in the rapidly changing Fourth Industrial Revolution with inherent values such as integrity and decentralization. We currently have about 70 employees, and more than 70% of them are experts in blockchain. We are hiring top engineers from South Korea and other countries continuously in order to enhance our blockchain technology.
Q. What was the reason that made you start blockchain business?
A. Since coming to know about blockchain technology for the first time in 2015, I have been studying the market and the technology with passion. During the process, I have become confident about business value and potential growth of blockchain technology. Because I had a faith that there would be a time when blockchain's technological nature and values' impact on the entire field of ICT will be maximized, I jumped into the business without any hesitation. Just like how Gartner is estimating that the global blockchain market will be worth $3.1 trillion in 2030, I predict that blockchain technology will assist digital innovation and establish itself as a key element throughout different industries.
Q. What is the reason that you are focusing on processing speed and performance of blockchain?
A. Medium's high-performance blockchain technology started with the fact that the current performance of blockchain does not meet the level of requirements for commercialization. Although most of blockchain companies are focusing on improving their blockchains from a software aspect, they have yet to come up with meaningful results. We believed that a blockchain hardware unit would be used to improve processing performance of blockchain. Although some companies throughout the world made attempts to prove our belief, no company has not been able to except Medium. We have been able to prove and improve our belief gradually. It will certainly take some time before blockchain technology is commercialized and becomes a universal technology. However, if it took ten years for cloud computing technology to be established as a universal technology, it will take much less time before blockchain technology is commercialized considering the digital transformation trend and the current climate of industries shifting towards contactless measures. Both public and financial industries continue to adopt blockchain technology, and blockchain technology will ultimately be used to process enormous amount of data from a global perspective. This is why we are focusing on developing stable and high-performance blockchain technology that can become a global and leading standard.
Q. Please explain the reason why Medium is pushing for development of a blockchain hardware.
A. Our goal when it comes to research and development is to implement high performance. We are currently conducting studies on improving performance of core technology that is the foundation for implementing high performance and maximizing implementation of high performance through processing exclusively for blockchain. This approach is a technological idea that is definitely different from other blockchain companies. We are continuing our studies on development of blockchain hardware to implement high performance.
Q. What are some characteristics of Medium Distributed Ledger?
While the capacity of Hyperledger Fabric (HLF) that is used the most globally is currently at about 3,000 TPS (Transactions Per Second), the capacity of MDL is 15,000 TPS. Compared to HLF, MDL provides five times better performance. It is also perfectly compatible with HLF allowing easy transition for the current HLF customers and it also makes interaction with other mutual settlement systems easier. MDL is becoming more improved each day so that its customers can focus on their businesses without having to worry about performance of blockchain core technology. We are also trying to eliminate any inconvenience in installing or using MDL by emphasizing easy installation and use throughout the MDL development process so that engineers and professionals who have difficulties in adopting and using blockchain technology can easily adopt and use blockchain technology.
Q. Tell us about few examples where Medium's superfast blockchain technology are currently used.
A. We recently signed a contract with Korea Minting and Security Printing Corporation (KOMSCO) regarding supplying our MDL blockchain solution and setting up a BMT (benchmark test) environment and had carried out necessary tasks. KOMSCO is currently participating in a blockchain-based project, which is led by many government agencies, and it also has a separate blockchain research department within its Information Technology Research Center to conduct various studies.
To set up a BMT environment for measuring performance of blockchain platforms including HLF, we had carried out a project that utilized our MDL solution and applied Hyperledger Caliper. We plan to continue to support KOMSCO with its studies on blockchain. We also supplied a MBPU (MEDIUM Blockchain Processing Unit) to Finger that is the overseeing agency of Korea Expressway Corporation's mutual trust settlement system construction project that was carried out this year as part of Korea Internet & Security Agency's research and development project. We are currently verifying technology regarding expandability and stability for rapid processing of transaction data in an overcrowded section of Hi-pass's settlement data in order to prepare for a commercialization process after this pilot project is completed well. Once a PoC (Proof of Concept) is carried out well, we plan to continue our strategic partnership with Finger.
Q. What is the reason behind so many positive reviews of "MDL Test Lab" that was made public in August from global companies?
A. Wipro, Tata Consultancy Services, and Infosys, which are the three major IT service providers in India that is responsible for 55% of IT sourcing tasks in the world, participated in MDL Test Lab. Blockchain-based database (DB) management system company called Peersafe based in China and an American system integration and consulting company called Cognizant also participated in MDL Test Lab. Most of these companies are top-tier IT companies that have more than 100,000 executives and employees.
Through MDL Test Lab that was carried out for about two months, we were able to confirm once again that our unique blockchain technical skills are useful globally. Actually, we are currently in discussions with companies that participated in MDL Test Lab about specific businesses. We even received an inquiry from a company based in Europe. Although we cannot disclose its name, it is a Greek company that specializes in ICT for the financial sector in Greece and we are in constant communications with the company.
Q. Please give us detailed information about the company's plan to expand its business towards software.
A. Our blockchain technology is able to provide performance that is far superior than that of HLF with just improvement in software. In order to have our customers adopt high-performance blockchain easily, we have introduced a business model that can be used as a form of software without a change in hardware. We expect that the model is able to greatly alleviate concerns such as cost and time that customers may face while adopting blockchain technology.
Q. Please explain any project or strategy that Medium is planning to create and vitalize its ecosystem.
A. The global blockchain market is still in an initial stage, and the blockchain market in South Korea is even more insignificant. According to a report from Software Policy & Research Institute, the entire revenue from the blockchain industry in 2019 was around $111 million (120 billion KRW). 87% of the revenue came from major companies, and these companies had an annual revenue of only $1.85 million (2 billion KRW) on average.
This report indicates that it is not easy to make revenue for startups in South Korea. Ultimately, startups need to target foreign markets, and we are one of the startups that are preparing a campaign to target the global blockchain market.
We have decided the code name of our campaign to be ARMY that is the same name as the fan club of BTS. ARMY played a major role in raising status of K-POP, which was seen as a nonmainstream music from a third-world country, in major markets in an instant by utilizing the YouTube platform. Now, ARMY is seen throughout the world. The goal of MDL ARMY Campaign is to create a group of global companies based on the MDL blockchain solution so that blockchain technology can be commercialized and grow globally after going through stages of PoC and verification.
Around 600 global companies are registered as part of our customer relationship management (CRM), and there are more than 2,000 contact points alone. Through the ARMY Campaign, we plan to supply the MDL solution to 1,000 customers by early 2021. We are able to provide technical support depending on requests from these companies, and the solution provided to the companies will develop into a subscribed model. We expect that this process will present a new standard to the distribution structure of global blockchain solutions that do not have a clear standard as of yet.
Q. How do you foresee blockchain industries in South Korea and other countries in long term?
A. Blockchain will bring an enormous amount of impact as its technological value becomes realized. Many companies are continuing their studies in order to apply blockchain technology to real life, and there needs to be a process of verifying blockchain's technological values through various forms of reference. This process is same as how innovative technologies such as AI and IoT (Internet of Things) have been applied to our lives, and I believe that the process will be much faster than other innovative technologies.
Digital transformation that is taking place globally due to the COVID-19 pandemic is triggering the process, and digital innovation is taking place globally in both public and private sectors at a speed that has never been seen before. This will lead to formation of blockchain markets through minor and major practical activities by government groups and companies and it can quickly lead to formation of a market on a global level.
Actually, many different fields such as mutual settlement or DID (Decentralized ID), distribution supply chain management (SCM), and digital asset and blockchain game are accelerating adoption of blockchain technology. Although no one can guarantee which industrial field will be the first one to open the gate of blockchain technology, how ready industrial fields are prepared for this rapid innovation will determine whether they will be the leaders or the followers in the global blockchain market.
Q. Please explain about the company's future goals including global plans.
A. Our company plans to focus entirely on the ARMY Campaign. Every executives and employees are meeting with global customers online and are already working very hard in commercializing and improving the MDL blockchain solution so that they are pleased with our solution. Although there are time differences, our engineers and salespeople are working day and night in order to communicate with customers.
The global blockchain market is already our goal and it will not change. We were able to verify the need for high-performance blockchain technology through MDL Test Lab and inquiries from global companies and we plan to implement performance that satisfies their requirements. We are extremely confident especially when it comes to blockchain technology. We are going to make more business opportunities with global companies in the next two years. We hope to inform the global blockchain market about the MDL solution through the ARMY campaign and create a mindset that blockchain that can be used in an everyday life is ultimately a high-performance blockchain technology through MDL.
XtLb $3.60 ** Co. seeking merger/partnership ** >> 3 Mill Float << Latest pr -> The Company is expanding its IP portfolio surrounding hCDR1 and has decided, at this time, to explore cooperation with a strategic partner in order to execute its clinical trials. In parallel, the Company will look to expand and identify additional assets to add to XTL’s portfolio.
Followers
|
252
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
819
|
Created
|
03/06/19
|
Type
|
Free
|
Moderator Shaz | |||
Assistants Carjockey2 |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |